Suzuki H, Sunada H
Fuji Laboratory, Janssen-Kyowa Co., Ltd, Shizuoka, Japan.
Chem Pharm Bull (Tokyo). 1998 Mar;46(3):482-7. doi: 10.1248/cpb.46.482.
The objective of this investigation was to clarify the influence of water-soluble polymers on the dissolution behavior of nifedipine from solid dispersions with combined carriers. All the solid dispersions of nifedipine were prepared by the fusion method using nicotinamide and 4 different water-soluble polymers, hydroxypropylmethyl-cellulose (HPMC), polyvinylpyrrolidone (PVP), partially hydrolyzed polyvinyl alcohol (PVA) and pullulan. HPMC, PVP or PVA dissolved in the fused liquid of nicotinamide and operated efficiently on the amorphous formation of nifedipine in solid dispersions. In dissolution studies, the drug concentration for these dispersions increased to more than twice intrinsic drug solubility. The rank order of the drug concentration was HPMC > PVP > PVA. However, since pullulan did not dissolve in the fused nicotinamide, nifedipine was present as a crystalline state in the solid dispersion; the supersaturation behavior of the drug was scarcely observed. The compatibility, namely, the solubility and miscibility, between nicotinamide or nifedipine and the polymers, was determined by differential scanning calorimetry using the mixtures treated with fusing and subsequent rapid cooling. Both HPMC and PVP exhibited high compatibility not only with nicotinamide but also with nifedipine. The crystallization behavior of nifedipine from a supersaturated solution containing nicotinamide or the polymers was studied. The inhibitory effect of HPMC or PVP for drug crystallization was evident, which would be related not to the solubilizing effect but to the adhesive force of the polymer for the drug. Therefore, it was understood that the use of a polymer with high compatibility and adhesion with nifedipine provides a high supersaturation level of the drug in dissolution. Further, the solubility parameter was found to be useful for selecting a suitable polymer as a component of combined carriers.
本研究的目的是阐明水溶性聚合物对硝苯地平在复合载体固体分散体中溶出行为的影响。硝苯地平的所有固体分散体均采用熔融法制备,使用烟酰胺和4种不同的水溶性聚合物,即羟丙基甲基纤维素(HPMC)、聚乙烯吡咯烷酮(PVP)、部分水解聚乙烯醇(PVA)和支链淀粉。HPMC、PVP或PVA溶解在烟酰胺的熔融液中,并有效地促进了硝苯地平在固体分散体中的无定形形成。在溶出度研究中,这些分散体的药物浓度增加到超过药物固有溶解度的两倍。药物浓度的顺序为HPMC>PVP>PVA。然而,由于支链淀粉不溶于熔融的烟酰胺,硝苯地平在固体分散体中以结晶状态存在;几乎未观察到药物的过饱和行为。通过差示扫描量热法,使用经过熔融和随后快速冷却处理的混合物,测定了烟酰胺或硝苯地平与聚合物之间的相容性,即溶解度和混溶性。HPMC和PVP不仅与烟酰胺而且与硝苯地平都表现出高相容性。研究了硝苯地平在含有烟酰胺或聚合物的过饱和溶液中的结晶行为。HPMC或PVP对药物结晶的抑制作用明显,这与增溶作用无关,而与聚合物对药物的粘附力有关。因此,可以理解,使用与硝苯地平具有高相容性和粘附性的聚合物可在溶出过程中提供高药物过饱和度水平。此外,发现溶解度参数有助于选择合适的聚合物作为复合载体的组分。